Related Experiment Videos

[Disorders of myocardial function in patients with normal coronary angiography]

P Kluge1

  • 1Abteilung für Kardiologie und Angiologie, Universität Leipzig.

Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|January 1, 1993
PubMed

Insights

Intraventricular contrast media injection during angiocardiography can reveal latent myocardial disease. An increase in left ventricular end-diastolic pressure (LVEDP) post-injection indicates preclinical heart conditions.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Myocardial Function

Context:

  • Assessing latent myocardial disease is crucial for early intervention.
  • Coronary heart disease (CHD) and angina pectoris present diagnostic challenges.
  • Angiocardiography is a key diagnostic tool in cardiovascular assessment.

Purpose:

  • To evaluate the utility of intraventricular contrast media injection in diagnosing preclinical myocardial disease.
  • To analyze cardiac function parameters, specifically left ventricular end-diastolic pressure (LVEDP), in response to contrast media.
  • To correlate changes in LVEDP with the severity of coronary heart disease.

Summary:

  • Left ventricular end-diastolic pressure (LVEDP) was measured in 350 patients before and after intraventricular contrast media injection.
  • Patients with coronary heart disease showed a significant LVEDP increase post-injection (23.7 mmHg) compared to those with normal coronary arteries (19.2 mmHg).
  • The contrast injection acts as a volume stress, revealing preclinical left ventricular myocardial disease through elevated LVEDP.

Impact:

  • This method can identify latent myocardial disease not apparent under resting conditions.
  • Ventriculography with contrast media provides a valuable non-invasive method for detecting early-stage heart conditions.
  • Early detection through this technique may lead to timely therapeutic interventions and improved patient outcomes.

Related Concept Videos